3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
10
Genitourinary
6
Thoracic
5
Gastrointestinal
5
Tumor-Agnostic
3
Head & Neck
3
Breast
3
Other hematologic neoplasm
2
Lymphoid
2
Gynecologic
2
CNS
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Conditions
Ovarian Neoplasms
16
Uterine Cervical Neoplasms
8
Melanoma
7
Colorectal Neoplasms
7
Fallopian Tube Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
5
Breast Neoplasms
5
Recurrence
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma
2
Endometrial Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Turcot syndrome
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Paclitaxel
28
Carboplatin
28
pembrolizumab
25
Bevacizumab
14
liposomal doxorubicin
12
Cisplatin
11
Gemcitabine
10
Radiotherapy
8
Drug Therapy
8
Cyclophosphamide
8
Blood Specimen Collection
8
Topotecan
7
Nivolumab
7
olaparib
6
Doxorubicin
6
niraparib
5
Therapeutics
5
Dexamethasone
5
pertuzumab
4
pazopanib
4
lenvatinib
4
fludarabine
4
cemiplimab
4
atezolizumab
4
Trastuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Fulvestrant
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms
×
Interleukin-2
×
Gynecologic
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled
NCT05086692
2025-07-09
ABILITY-1
Medicenna Therapeutics, Inc.
Phase 1/2
Recruiting
115 enrolled